Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Van den Brulle

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2010
The novel activated microglia/macrophage WAP domain protein, AMWAP, acts as a counter-regulator of proinflammatory responseMarcus Karlstetter, Yana Walczak, Karin Weigelt, et al.
Analytical Biochemistry|April 3, 2007
A high-throughput screening platform for inhibitors of the riboflavin biosynthesis pathwayJohannes Kaiser, Boris Illarionov, Felix Rohdich, et al.
Biotechniques|September 10, 2008
A novel solid phase technology for high-throughput gene synthesisJan Van den Brulle, Markus Fischer, Thomas Langmann, et al.
Journal of Immunotoxicology|December 10, 2024
Identifying CD19-targeted CAR-T cell immune pathways in an in vitro human immune mimetic cytokine release assayThuvan Dinh-Le, John Escobar, Louis Poisson, et al.
Plos Genetics|November 30, 2016
High-Resolution Phenotypic Landscape of the RNA Polymerase II Trigger LoopChenxi Qiu, Olivia C Erinne, Jui M Dave, et al.
Plos Genetics|January 4, 2018
Correction: High-Resolution Phenotypic Landscape of the RNA Polymerase II Trigger LoopChenxi Qiu, Olivia C Erinne, Jui M Dave, et al.
Journal of Molecular Biology|July 27, 2011
Synthetic antibodies designed on natural sequence landscapesWenwu Zhai, Jacob Glanville, Markus Fuhrmann, et al.
Journal of Immunotoxicology|December 10, 2024
Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway conceptMiriam Alb, Kristin Reiche, Michael Rade, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time to evolve: predicting engineered T cell-associated toxicity with next-generation modelsEmmanuel Donnadieu, Maik Luu, Miriam Alb, et al.
Cytotherapy|November 11, 2025
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in EuropeDelphine Ammar, Carmen Sanges, David Henderson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2010
The novel activated microglia/macrophage WAP domain protein, AMWAP, acts as a counter-regulator of proinflammatory responseMarcus Karlstetter, Yana Walczak, Karin Weigelt, et al.
Analytical Biochemistry|April 3, 2007
A high-throughput screening platform for inhibitors of the riboflavin biosynthesis pathwayJohannes Kaiser, Boris Illarionov, Felix Rohdich, et al.
Biotechniques|September 10, 2008
A novel solid phase technology for high-throughput gene synthesisJan Van den Brulle, Markus Fischer, Thomas Langmann, et al.
Journal of Immunotoxicology|December 10, 2024
Identifying CD19-targeted CAR-T cell immune pathways in an in vitro human immune mimetic cytokine release assayThuvan Dinh-Le, John Escobar, Louis Poisson, et al.
Plos Genetics|November 30, 2016
High-Resolution Phenotypic Landscape of the RNA Polymerase II Trigger LoopChenxi Qiu, Olivia C Erinne, Jui M Dave, et al.
Plos Genetics|January 4, 2018
Correction: High-Resolution Phenotypic Landscape of the RNA Polymerase II Trigger LoopChenxi Qiu, Olivia C Erinne, Jui M Dave, et al.
Journal of Molecular Biology|July 27, 2011
Synthetic antibodies designed on natural sequence landscapesWenwu Zhai, Jacob Glanville, Markus Fuhrmann, et al.
Journal of Immunotoxicology|December 10, 2024
Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway conceptMiriam Alb, Kristin Reiche, Michael Rade, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time to evolve: predicting engineered T cell-associated toxicity with next-generation modelsEmmanuel Donnadieu, Maik Luu, Miriam Alb, et al.
Cytotherapy|November 11, 2025
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in EuropeDelphine Ammar, Carmen Sanges, David Henderson, et al.
Pageof 1